In an elderly patient, should I prescribe Jardiance (empagliflozin) or a GLP-1 (glucagon-like peptide-1) receptor agonist for glycemic control?
At our clinic, the joint pain patients who see the most benefit from BPC-157 are those with chronic knee, shoulder, or hip pain that has plateaued after standard orthopedic treatment, particularly where inflammatory load is a significant component of the symptom picture
What to Expect Nothing about the dosing week is meant to feel dramatic
Association between immune cells, inflammatory cytokines, and sarcopenia: Insights from a Mendelian randomization analysis
Ozempic face is another commonly reported consequences of using these popular weight loss drugs
Endurance athletes and lifters (They're good for anyone wishing to be a tyrant.) Low-dietary intake in vegans or vegetarians